In this study, we compared the clinical characteristics, regional amyloid and tau depositions, and cortical thickness among Aß+ APOE4 carriers, Aß+ APOE4 non-carriers, and normal controls to assess correlations between the APOE4 allele and AD-related biomarker burdens in cognitively normal elderly people. This evidence concerns the gene MAPT and Alzheimer disease.